24 results on '"Yuki Komabayashi"'
Search Results
2. Hypopharyngeal Diffuse Large B-Cell Lymphoma in a 74-Year-Old Man Presenting with Dysphagia: A Case Report.
- Author
-
Hisataka Ominato, Yuki Komabayashi, Shiori Suzuki, Isamu Kunibe, Takumi Kumai, and Miki Takahara
- Subjects
- *
DIFFUSE large B-cell lymphomas , *CANCER relapse , *DEGLUTITION disorders , *SQUAMOUS cell carcinoma - Abstract
Objective: Unusual clinical course Background: Malignant lymphomas can occur at various sites. Hypopharyngeal tumors are at risk for airway obstruction and require rapid diagnosis and treatment. Most hypopharyngeal malignancies are squamous cell carcinomas; other tumors are rare. To date, only a few cases of malignant hypopharyngeal lymphoma have been reported, and its specific characteristics are unknown. Herein, we report a case of right hypopharyngeal diffuse large B-cell lymphoma (DLBCL) in a 74-year-old man with dysphagia. Case Report: A 74-year-old man presented to our hospital with dysphagia. He had no relevant medical history. Endoscopic examination revealed a right hypopharyngeal tumor. The surface of the tumor was smooth, with no evidence of hemorrhage. Computed tomography revealed a 40-mm mass located in the hypopharynx. We performed a tracheotomy and biopsy of the tumor. Histopathological examination revealed a diffuse proliferation of large atypical B cells with negative staining for Epstein-Barr virus by in situ hybridization. Immunohistochemical staining was positive for CD20 but negative for CD3 and CD10. The patient was administered chemotherapy. The tumor reduced in size, and the patient recovered completely. During the two-year follow up, no recurrence of cancer was observed. Conclusions: Although most hypopharyngeal tumors are squamous cell carcinomas (SCCs), the possibility of other types of tumors should also be considered. Malignant lymphoma of the hypopharynx is rare, and more cases need to be studied and reported in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Cervical Emphysema and Pneumomediastinum Caused by a Nasogastric Tube: A Case Report
- Author
-
Hisataka Ominato, Yuki Komabayashi, Shiori Suzuki, and Isamu Kunibe
- Subjects
General Medicine - Published
- 2023
- Full Text
- View/download PDF
4. A Case of Isolated Malleus Fracture Caused by Negative Pressure
- Author
-
Takahiro Inoue, Isamu Kunibe, Tomoki Fujiwara, Yuki Komabayashi, Takumi Kumai, Kan Kishibe, Miki Takahara, Akihiro Katada, and Tatsuya Hayashi
- Subjects
Otorhinolaryngology - Published
- 2022
- Full Text
- View/download PDF
5. Hypopharyngeal Diffuse Large B-Cell Lymphoma in a 74-Year-Old Man Presenting with Dysphagia: A Case Report.
- Author
-
Hisataka Ominato, Yuki Komabayashi, Shiori Suzuki, Isamu Kunibe, Takumi Kumai, and Miki Takahara
- Subjects
DIFFUSE large B-cell lymphomas ,CANCER relapse ,DEGLUTITION disorders ,SQUAMOUS cell carcinoma - Abstract
Objective: Unusual clinical course Background: Malignant lymphomas can occur at various sites. Hypopharyngeal tumors are at risk for airway obstruction and require rapid diagnosis and treatment. Most hypopharyngeal malignancies are squamous cell carcinomas; other tumors are rare. To date, only a few cases of malignant hypopharyngeal lymphoma have been reported, and its specific characteristics are unknown. Herein, we report a case of right hypopharyngeal diffuse large B-cell lymphoma (DLBCL) in a 74-year-old man with dysphagia. Case Report: A 74-year-old man presented to our hospital with dysphagia. He had no relevant medical history. Endoscopic examination revealed a right hypopharyngeal tumor. The surface of the tumor was smooth, with no evidence of hemorrhage. Computed tomography revealed a 40-mm mass located in the hypopharynx. We performed a tracheotomy and biopsy of the tumor. Histopathological examination revealed a diffuse proliferation of large atypical B cells with negative staining for Epstein-Barr virus by in situ hybridization. Immunohistochemical staining was positive for CD20 but negative for CD3 and CD10. The patient was administered chemotherapy. The tumor reduced in size, and the patient recovered completely. During the two-year follow up, no recurrence of cancer was observed. Conclusions: Although most hypopharyngeal tumors are squamous cell carcinomas (SCCs), the possibility of other types of tumors should also be considered. Malignant lymphoma of the hypopharynx is rare, and more cases need to be studied and reported in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Stapes Bar—Normal Stapedial Superstructure with a Mobile Footplate Fixed to the Promontory
- Author
-
Shiori Suzuki, Isamu Kunibe, Hisataka Ominato, and Yuki Komabayashi
- Subjects
Otorhinolaryngology - Abstract
This report describes a case of stapedial superstructure fixation with a mobile footplate, which is a rare occurrence among the ossicular malformations that cause conductive hearing impairment. A 44-year-old man with symptoms of left-sided hearing impairment since childhood presented to our department. The eardrum was normal, and pure tone audiometry showed conductive hearing impairment with a three-frequency (500, 1000, and 2000 Hz) mean of 53.3 dB and a normal tympanogram result. An abnormal shadow was observed on the internal side of the left stapes during the three-dimensional reconstruction of computed tomography. We suspected a stapes malformation and performed an exploratory tympanotomy with transcanal endoscopic ear surgery. We found a bony bar between the superstructure of the stapes and the promontory. The mobility of the stapes was significantly improved by removing the bony bar. Findings of postoperative audiometry were normal after surgery. The treatment of such cases of stapedial fixation is simple, and the prognosis of hearing gain after surgery is quite good. Thus, regarding the treatment of patients with conductive hearing impairment, clinicians and surgeons should be aware of the possibility of single stapedial superstructure fixation.
- Published
- 2023
- Full Text
- View/download PDF
7. Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma
- Author
-
Toshihiro Nagato, Miki Takahara, Shohei Harabuchi, Kan Kishibe, Seigo Ueda, Takumi Kumai, Michele Bernasconi, Kenzo Ohara, Yui Hirata-Nozaki, Hiroya Kobayashi, Yasuaki Harabuchi, Yuki Komabayashi, David Nadal, Takayuki Ohkuri, and Ryusuke Hayashi
- Subjects
Male ,0301 basic medicine ,Survivin ,Nose Neoplasms ,Mice, SCID ,Biology ,Lymphoma, T-Cell ,Pathology and Forensic Medicine ,Viral Matrix Proteins ,03 medical and health sciences ,0302 clinical medicine ,Downregulation and upregulation ,Mice, Inbred NOD ,Cell Line, Tumor ,Antineoplastic Combined Chemotherapy Protocols ,CDC2 Protein Kinase ,medicine ,Animals ,Humans ,Molecular Biology ,Mice, Knockout ,Gene knockdown ,Cyclin-dependent kinase 1 ,Kinase ,Plicamycin ,Cell Biology ,Middle Aged ,Natural killer T cell ,medicine.disease ,Xenograft Model Antitumor Assays ,Lymphoma ,Killer Cells, Natural ,030104 developmental biology ,Cell culture ,030220 oncology & carcinogenesis ,Cancer research ,Female ,RNA Interference ,biological phenomena, cell phenomena, and immunity - Abstract
Nasal natural killer/T-cell lymphoma (NNKTL) is closely associated with Epstein-Barr virus (EBV) and is characterized by poor prognosis, resulting from rapid progression of lesions in the affected organs. Recent data have shown that NNKTL is associated with the aberrant expression of cyclin-dependent kinase 1 (CDK1) and its downstream target survivin, but little is known about the functional roles of CDK1 and survivin in NNKTL. In the current study, we show that knockdown of the EBV-encoded oncoprotein latent membrane protein 1 (LMP1) induces downregulation of CDK1 and survivin in NNKTL cells. Immunohistochemistry detected CDK1 and survivin expression in LMP1-positive cells of NNKTL biopsy specimens. Inhibition of CDK1 and survivin in NNKTL cells with several inhibitors led to a dose-dependent decrease in cell proliferation. In addition, the Sp1 inhibitor mithramycin, which can downregulate both CDK1 and survivin, significantly suppressed the growth of established NNKTL in a murine xenograft model. Our results suggest that LMP1 upregulation of CDK1 and survivin may be essential for NNKTL progression. Furthermore, targeting CDK1 and survivin with Sp1 inhibitors such as mithramycin may be an effective approach to treat NNKTL, which is considered to be a treatment-refractory lymphoma.
- Published
- 2019
- Full Text
- View/download PDF
8. Endoscopic Resection of a Massive Pleomorphic Adenoma of the Nasal Septum
- Author
-
Yasuaki Harabuchi, Akinobu Kubota, Yuki Komabayashi, and Isamu Kunibe
- Subjects
Nasal cavity ,medicine.medical_specialty ,business.industry ,Endoscopic surgery ,medicine.disease ,Benign tumor ,Resection ,Pleomorphic adenoma ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Major Salivary Gland ,medicine ,Nasal septum ,Endoscopic resection ,Radiology ,030223 otorhinolaryngology ,business - Abstract
Pleomorphic adenoma is a benign tumor that commonly arises from the major salivary glands, such as the parotid and submandibular glands. However, they rarely originate from the nasal cavity. Herein, we describe the case of a 49-year-old woman who presented with nasal obstruction. Preoperative evaluation revealed a giant pleomorphic adenoma attached to the nasal septum. Transnasal endoscopic removal was successfully performed using a specimen retrieval bag. We performed an endoscopic complete en-bloc resection of a large pleomorphic adenoma in the nasal cavity, using a specimen retrieval bag. There were no complications seen, no local recurrences after 2 years of follow-up, and the patient satisfaction was high. We therefore recommend that this technique of using specimen retrieval bags can be favorably utilized for endoscopic removal of large nasal tumors like pleomorphic adenoma.
- Published
- 2021
- Full Text
- View/download PDF
9. Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma
- Author
-
Miki Takahara, Yuki Komabayashi, Yasuaki Harabuchi, Seigo Ueda, Toshihiro Nagato, and Kan Kishibe
- Subjects
0301 basic medicine ,Cancer Research ,Hematology ,General Medicine ,Biology ,medicine.disease ,medicine.disease_cause ,Natural killer T cell ,Epstein–Barr virus ,Virus ,Lymphoma ,Pathogenesis ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Real-time polymerase chain reaction ,Oncology ,030220 oncology & carcinogenesis ,Gene expression ,microRNA ,Immunology ,medicine - Abstract
Nasal natural killer/T-cell lymphoma (NNKTL) is an Epstein-Barr virus (EBV)-associated malignancy and is characterized by local invasion and widespread dissemination, with a consequent poor prognosis. Micro-RNAs (miRNAs) play roles in the pathogenesis of several malignancies by regulating gene expression and have been recently identified as stable entities in serum. Here, we investigated the value of circulating EBV-miRNAs as biomarkers for NNKTL. Sera of patients with NNKTL were subjected to miRNA polymerase chain reaction (PCR)-array analysis, after which serum EBV-miRNA levels were verified using quantitative PCR. The latter analysis revealed high miR-BART2-5p, miR-BART7-3p, miR-BART13-3p, and miR-BART1-5p expression levels in sera of patients with NNKTL and indicated accurate values for discriminating patients with NNKTL from healthy controls. Levels of these 4 EBV-miRNAs, which were secreted from NNKTL cells, significantly decreased after treatment compared with those before treatment. Furthermore, a high circulating miR-BART2-5p level was associated with disease progression and poor prognosis in patients with NNKTL. Our findings demonstrate that circulating EBV-miRNAs, particularly miR-BART2-5p, may serve as potential diagnostic and prognostic biomarkers in patients with NNKTL.
- Published
- 2016
- Full Text
- View/download PDF
10. Two Cases of Optic Nerve Neuropathy from Graves’ Ophthalmopathy Treated by Endoscopic Orbital Decompression
- Author
-
Noriko Nishikawa, Kenichiro Nomura, Harumasa Yokota, Kan Kishibe, Akihiro Katada, Akihiro Katayama, Toshihiro Nagato, Tatsuya Hayashi, Yasuaki Harabuchi, and Yuki Komabayashi
- Subjects
Graves' ophthalmopathy ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,Orbital decompression ,030221 ophthalmology & optometry ,Optic nerve ,medicine ,030209 endocrinology & metabolism ,medicine.disease ,business ,Surgery - Published
- 2016
- Full Text
- View/download PDF
11. Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy
- Author
-
Miki Takahara, Yuki Komabayashi, Masaaki Yamashina, Toshihiro Nagato, Seigo Ueda, Yasuaki Harabuchi, Kouji Takahashi, and Kan Kishibe
- Subjects
Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Gastroenterology ,Nose neoplasm ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,medicine ,Mucositis ,Etoposide ,Chemotherapy ,business.industry ,Hematology ,General Medicine ,medicine.disease ,Carboplatin ,Surgery ,Regimen ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,Concomitant ,business ,Chemoradiotherapy ,030215 immunology ,medicine.drug - Abstract
Nasal natural killer (NK)/T-cell lymphoma (NNKTL) displays unusual clinicopathological features, and the prognosis is very poor, even in the early stages of the disease. For early stage NNKTL, we have developed a novel chemoradiotherapy regimen incorporating arterial infusion chemotherapy, administered via the superficial temporal artery, in combination with radiotherapy. The novel arterial infusion regimen consists of ifosfamide, carboplatin, methotrexate, peplomycin, and etoposide (MPVIC-P). From 2003 to 2011, 12 patients with early stage NNKTL were treated with the MPVIC-P regimen via arterial infusion with concomitant radiotherapy (54 Gy). We have previously reported on the presence of Epstein-Barr virus (EBV) genetic DNA in NNKTL. Therefore, the effect of the treatment was evaluated by using both clinical findings and serum EBV DNA copy number. The observation period ranged from 39 months to 111 months post-treatment (median: 81 months). All 12 patients achieved and maintained complete remission and, to date, show no sign of relapse. Serum EBV DNA copy numbers decreased to below detectable levels in all 12 patients tested. Manageable mucositis was the most common grade 3-4 toxicity, and it was seen in 10 (83%) patients. However, grade 3-4 hematological toxicity was only seen in 4 (33%) patients. We conclude that our regimen of intra-maxillary arterial chemotherapy with concomitant radiotherapy is an effective treatment with minimal toxicity for early stage NNKTL. Copyright © 2015 John Wiley & Sons, Ltd.
- Published
- 2015
- Full Text
- View/download PDF
12. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma
- Author
-
Miki Takahara, Kan Kishibe, Toshihiro Nagato, Yuki Komabayashi, Seigo Ueda, and Yasuaki Harabuchi
- Subjects
Adult ,Male ,cyclin D1 ,Down-Regulation ,Biology ,Viral Matrix Proteins ,Nasal natural killer/T cell lymphoma ,Cyclin D1 ,Downregulation and upregulation ,Cell Line, Tumor ,microRNA ,Humans ,Epstein-Barr virus ,MYB ,Epstein-Barr virus latent membrane protein 1 ,Aged ,Cell Proliferation ,Neoplasm Staging ,Regulation of gene expression ,Aged, 80 and over ,Gene knockdown ,旭川医科大学:博士(医学)(乙449号) ,Cell growth ,v-myb myeloblastosis viral oncogene homolog ,Hematology ,Transfection ,Cell Cycle Checkpoints ,Middle Aged ,Prognosis ,Molecular biology ,Oncogene Proteins v-myb ,Gene Expression Regulation, Neoplastic ,Lymphoma, Extranodal NK-T-Cell ,MicroRNAs ,microRNA-15a ,Cancer research ,Female - Abstract
Nasal NK/T-cell lymphoma (NNKTL) is an Epstein-Barr virus (EBV)-associated malignancy and has distinct clinical and histological features. However, its genetic features are hitherto unclear. MicroRNAs (miRNAs) play a crucial role in the pathogenesis of several malignancies via regulating gene expression. In this study, we investigated whether the specific microRNAs were related to the tumor behaviors in NNKTL. MiRNA array and Quantitative RT-PCR analyses revealed that miR-15a was expressed at a much lower level in NNKTL cells (SNK-1, SNK-6, and SNT-8) than in normal peripheral NK cells and EBV-negative NK cell line KHYG-1. Quantitative PCR and western blot analyses showed that the expression of MYB and cyclin D1, which are validated targets of miR-15a, was higher in NNKTL cells. Transfection of NNKTL cells (SNK-6 and SNT-8) with a miR-15a precursor decreased MYB and cyclin D1 levels, thereby blocking G1/S transition and cell proliferation. Knockdown of EBV-encoded latent membrane protein 1 (LMP1) significantly increased miR-15a expression in SNK-6 cells. In NNKTL tissues, we found that reduced miR-15a expression, which correlated with MYB and cyclin D1 expression, was associated with poor prognosis of NNKTL patients. These data suggest that downregulation of miR-15a, possibly due to LMP1, implicates in the pathogenesis of NNKTL by inducing cell proliferation via MYB and cyclin D1. Thus, miR-15a could be a potential target for antitumor therapy and a prognostic predictor for NNKTL.
- Published
- 2014
13. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy
- Author
-
Takumi Kumai, Takayuki Ohkuri, Kei Ishibashi, Toshihiro Nagato, Hiroya Kobayashi, Hidehiro Takei, Akemi Kosaka, Yui Hirata, Seigo Ueda, Yuji Uno, Yuki Komabayashi, Kan Kishibe, Miki Takahara, Kenzo Ohara, Masatoshi Sado, Yasuaki Harabuchi, Naoko Aoki, Naoko Akiyama, Esteban Celis, and Kensuke Oikawa
- Subjects
0301 basic medicine ,Adult ,Male ,Cancer Research ,medicine.medical_treatment ,Biopsy ,Immunology ,Nose Neoplasms ,Programmed Cell Death 1 Receptor ,Kaplan-Meier Estimate ,B7-H1 Antigen ,Disease-Free Survival ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Immune system ,PD-L1 ,Cell Line, Tumor ,medicine ,Immunology and Allergy ,Neoplasm ,Animals ,Humans ,Aged ,Aged, 80 and over ,medicine.diagnostic_test ,biology ,Immunotherapy ,Middle Aged ,medicine.disease ,Natural killer T cell ,Prognosis ,Lymphoma ,Lymphoma, Extranodal NK-T-Cell ,030104 developmental biology ,Oncology ,Cell culture ,030220 oncology & carcinogenesis ,biology.protein ,Heterografts ,Female - Abstract
Nasal natural killer/T-cell lymphoma (NNKTL) is an aggressive neoplasm with poor therapeutic responses and prognosis. The programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) pathway plays an important role in immune evasion of tumor cells through T-cell exhaustion. The aim of the present study was to examine the expression of PD-L1 and PD-1 molecules in NNKTL. We detected the expression of PD-L1 in biopsy samples from all of the NNKTL patients studied. PD-L1 was found on both malignant cells and tumor-infiltrating macrophages, while PD-1-positive mononuclear cells infiltrated the tumor tissues in 36% of patients. Most significantly, soluble PD-L1 (sPD-L1) was present in sera of NNKTL patients at higher levels as compared to healthy individuals and the levels of serum sPD-L1 in patients positively correlated with the expression of PD-L1 in lymphoma cells of tumor tissues. In addition, the high-sPD-L1 group of patients showed significantly worse prognosis than the low-sPD-L1 group. Furthermore, we confirmed that membrane and soluble PD-L1 was expressed on the surface and in the culture supernatant, respectively, of NNKTL cell lines. The expression of PD-L1 was observed in tumor tissues and sera from a murine xenograft model inoculated with an NNKTL cell line. Our results suggest that sPD-L1 could be a prognostic predictor for NNKTL and open up the possibility of immunotherapy of this lymphoma using PD-1/PD-L1 axis inhibitors.
- Published
- 2016
14. Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma
- Author
-
Yuki, Komabayashi, Kan, Kishibe, Toshihiro, Nagato, Seigo, Ueda, Miki, Takahara, and Yasuaki, Harabuchi
- Subjects
Adult ,Male ,Epstein-Barr Virus Infections ,Herpesvirus 4, Human ,Gene Expression Profiling ,Kaplan-Meier Estimate ,Middle Aged ,Exosomes ,Prognosis ,Combined Modality Therapy ,Lymphoma, Extranodal NK-T-Cell ,MicroRNAs ,Young Adult ,Treatment Outcome ,ROC Curve ,Cell Line, Tumor ,Humans ,RNA, Viral ,Female ,Biomarkers ,Aged - Abstract
Nasal natural killer/T-cell lymphoma (NNKTL) is an Epstein-Barr virus (EBV)-associated malignancy and is characterized by local invasion and widespread dissemination, with a consequent poor prognosis. Micro-RNAs (miRNAs) play roles in the pathogenesis of several malignancies by regulating gene expression and have been recently identified as stable entities in serum. Here, we investigated the value of circulating EBV-miRNAs as biomarkers for NNKTL. Sera of patients with NNKTL were subjected to miRNA polymerase chain reaction (PCR)-array analysis, after which serum EBV-miRNA levels were verified using quantitative PCR. The latter analysis revealed high miR-BART2-5p, miR-BART7-3p, miR-BART13-3p, and miR-BART1-5p expression levels in sera of patients with NNKTL and indicated accurate values for discriminating patients with NNKTL from healthy controls. Levels of these 4 EBV-miRNAs, which were secreted from NNKTL cells, significantly decreased after treatment compared with those before treatment. Furthermore, a high circulating miR-BART2-5p level was associated with disease progression and poor prognosis in patients with NNKTL. Our findings demonstrate that circulating EBV-miRNAs, particularly miR-BART2-5p, may serve as potential diagnostic and prognostic biomarkers in patients with NNKTL.
- Published
- 2016
15. Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27
- Author
-
Toshihiro Nagato, Yuki Komabayashi, Yasuaki Harabuchi, Kan Kishibe, Kazumi Yoshino, Seigo Ueda, and Miki Takahara
- Subjects
Adult ,Cytotoxicity, Immunologic ,Male ,Nose Neoplasms ,Gene Expression ,medicine.disease_cause ,Antibodies ,Viral Matrix Proteins ,Cell Line, Tumor ,medicine ,Humans ,T-cell lymphoma ,biology ,Cell growth ,Hematology ,Epstein–Barr virus latent membrane protein 1 ,Middle Aged ,medicine.disease ,Natural killer T cell ,Epstein–Barr virus ,Tumor Necrosis Factor Receptor Superfamily, Member 7 ,Lymphoma, Extranodal NK-T-Cell ,Reverse transcription polymerase chain reaction ,Cell culture ,Cancer research ,biology.protein ,RNA, Viral ,Female ,Antibody ,CD27 Ligand ,Protein Binding - Abstract
Nasal natural killer (NK)/T cell lymphoma (NNKTL) is associated with Epstein-Barr virus (EBV). The present study analysed gene expression patterns of the NNKTL cell lines SNK6, SNK1 and SNT8, which are positive for EBV and latent membrane protein (LMP)-1, using a complementary DNA array analysis. We found that CD70 was specifically expressed in SNK6 and SNT8. Reverse transcription polymerase chain reaction and flow cytometric analyses confirmed that CD70 was expressed in all 3 NNKTL cell lines, but not in the other EBV-positive NK-cell lines. In vitro studies showed that NNKTL cell lines proliferated, in a dose-dependent fashion, in response to exogenous soluble CD27, which is the ligand for CD70. In NNKTL patients, we confirmed that the CD70 was expressed on the lymphoma cells in NNKTL tissues and that soluble CD27 was present in sera at higher levels as compared to healthy individuals. Finally, complement-dependent cytotoxicity assay showed that anti-CD70 antibody mediated effective complement-dependent killing of NNKTL cells and the affected target CD70 expression on the cells. These results suggest that CD70 acts as a functional receptor binding to soluble CD27, resulting in lymphoma progression and that immunotherapy using anti-CD70 antibody may be a potential candidate for treatment for NNKTL.
- Published
- 2012
- Full Text
- View/download PDF
16. A Case of Angioedema Requiring Emergent Tracheostomy
- Author
-
Kan Kishibe, Akihiro Katayama, Isamu Kunibe, Akihiro Katada, Yasuaki Harabuchi, Tatsuya Hayashi, and Yuki Komabayashi
- Subjects
medicine.medical_specialty ,Angioedema ,business.industry ,medicine ,medicine.symptom ,business ,Surgery - Abstract
今回われわれは,緊急気管切開を要した血管浮腫の1例を経験したので報告する。症例は,62歳男性である。頸部,舌の腫脹を主訴に当科を受診した。舌および喉頭に高度な浮腫を認めた。血管浮腫の診断で緊急気管切開を施行したが,術中に呼吸苦の増悪を認め,呼吸停止した。呼吸停止直後輪状甲状膜切開を行い,気道を確保した。アンギオテンシン変換酵素阻害薬,アンギオテンシンII受容体拮抗薬を内服しており血管浮腫の原因薬として疑い休薬し,その後浮腫の再発を認めていない。アンギオテンシン変換酵素阻害薬の副作用として血管浮腫が知られており,稀ではあるが重篤な経過をたどることがあり注意を要する。
- Published
- 2011
- Full Text
- View/download PDF
17. A Case of Anaplastic Thyroid Carcinoma in the Lateral Neck
- Author
-
Akihiro Katayama, Yasuaki Harabuchi, Chikako Yoshida, Mitsuru Asanome, Kazuhiko Hokunan, and Yuki Komabayashi
- Subjects
Oncology ,endocrine system ,medicine.medical_specialty ,endocrine system diseases ,Ectopic thyroid ,business.industry ,Neck mass ,Thyroid ,medicine.disease ,Thyroid carcinoma ,medicine.anatomical_structure ,Otorhinolaryngology ,Internal medicine ,Carcinoma ,medicine ,Anaplastic carcinoma ,Radiology ,medicine.symptom ,business ,Cervix ,Internal jugular vein - Abstract
We report a case of anaplastic thyroid carcinoma of the left lateral cervix. A 72-year-old woman undergoing surgery for a left neck mass behind the internal jugular vein was found pathologically to have anaplastic carcinoma with partial papillary thyroid carcinoma. Although ultrasonography and computed tomography showed no tumor in the thyroid gland, we conducted total thyroidectomy. No carcinoma was detected pathologically in the specimen and no recurrence was seen two years after treatment. These findings are insufficient, however, to diagnose either occult thyroid carcinoma or ectopic thyroid carcinoma.
- Published
- 2010
- Full Text
- View/download PDF
18. A Case with a Shotgun Wound to the Cheek in which the Bullet was Retained in the Maxillary Sinus
- Author
-
Akihiro Katayama, Yasuaki Harabuchi, Yuki Komabayashi, and Takashi Osaki
- Subjects
medicine.medical_specialty ,integumentary system ,Maxillary sinus ,business.industry ,Shotgun ,Anatomy ,Cheek ,Shotgun wound ,Surgery ,Nasal bleeding ,CHEEK PAIN ,body regions ,Bullet wound ,stomatognathic diseases ,Endoscopic sinus surgery ,medicine.anatomical_structure ,stomatognathic system ,Otorhinolaryngology ,medicine ,business - Abstract
Gunshot wounds are uncommon in Japan because gun possession is illegal. We report a case with a shotgun wound to the cheek. The patient was a 64-year-old man who was accidentally shot with a shotgun while hunting. He was alert and had no apparent neurological defects. He complained of cheek pain and nasal bleeding, and a bullet wound was observed in his left cheek. Computed tomography revealed a bullet lodged in the left maxillary sinus. We removed the bullet during endoscopic sinus surgery.
- Published
- 2009
- Full Text
- View/download PDF
19. A Case of Synovial Sarcoma of the Larynx
- Author
-
Naoko Aoki, Akihiro Katada, Toshihiro Nagato, Yasuaki Harabuchi, Masanobu Imada, Ryo Ota, Yuki Komabayashi, Nobuyuki Bando, Tatsuya Hayashi, and Takeshi Ogino
- Subjects
Larynx ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Soft tissue ,medicine.disease ,Malignancy ,Synovial sarcoma ,Surgery ,Laryngectomy ,Radiation therapy ,Pyriform Sinus ,medicine.anatomical_structure ,Otorhinolaryngology ,Biopsy ,otorhinolaryngologic diseases ,medicine ,business - Abstract
Synovial sarcoma is a mescenchymal malignancy which accounts for approximately 10% of all soft tissue sarcomas. It usually occurs in the lower limbs of young adults, and only 3% of all synovial sarcomas involve the head and neck region. As the incidence in the head and neck region is very low, only 11 cases with endolaryngeal localization have been reported in the world. We report a case of synovial sarcoma of the larynx.The patient was a 50-year-old man, complaining of swallowing difficulty. The tumor existed in the left arytenoid and pyriform sinus. Histological diagnosis obtained by biopsy was synovial sarcoma.As total laryngectomy as a initial treatment was refused, superselective arterial infusion of high-dose cisplatin with concurrent radiotherapy was performed. The effect of the treatment was insufficient after four trials of arterial infusion at one-week intervals and 40Gy radiation. He finally consented to undergo total laryngectomy. No recurrence has been observed for 18 months after surgery.
- Published
- 2007
- Full Text
- View/download PDF
20. A Case of a Lingual Dermoid Cyst
- Author
-
Yuki Komabayashi, Hayabusa Nozawa, Tetsuji Wada, Yasuaki Harabuchi, and Naoki Kanai
- Subjects
Dorsum ,medicine.medical_specialty ,business.industry ,Anatomy ,Histopathological examination ,medicine.disease ,Surgery ,stomatognathic diseases ,medicine.anatomical_structure ,stomatognathic system ,Otorhinolaryngology ,Painful tongue ,Dermoid cyst ,Tongue ,External approach ,otorhinolaryngologic diseases ,medicine ,Swelling ,medicine.symptom ,business ,After treatment - Abstract
Lingual dermoid cysts are uncommon. To date, there have been twenty reported cases. We report an additional case of lingual dermoid cyst. The patient was a sixteen-year-old girl. She was referred to our clinic for painful tongue swelling. A firm, tender lingual mass with purulent drainage from the midline of the dorsum of the tongue was noted. After treatment with antibiotics and drainage, the size of the mass reduced gradually. Eight months later, regrowth of the mass was observed. The mass was totally excised via an oral and external approach. According to histopathological examination, the mass was diagnosed as dermoid cyst.
- Published
- 2007
- Full Text
- View/download PDF
21. A Case of Chondrosarcoma of the Larynx
- Author
-
Yuki Komabayashi, Masanobu Imada, Toshitaka Toutani, Kan Kishibe, Miki Takahara, Takeshi Ogino, Satoshi Nonaka, and Yasuaki Harabuchi
- Subjects
Otorhinolaryngology - Published
- 2005
- Full Text
- View/download PDF
22. Case of an Intraorbital Wooden Foreign Body Penetrating the Maxillary Sinus
- Author
-
Hiroshi Osanai, Satoshi Nonaka, Atsuyoshi Asahi, Masanobu Imada, Yuki Komabayashi, Nobuyuki Bandou, and Yasuaki Harabuchi
- Subjects
Diplopia ,medicine.medical_specialty ,genetic structures ,medicine.diagnostic_test ,Maxillary sinus ,business.industry ,Granulation tissue ,Magnetic resonance imaging ,Anatomy ,medicine.disease ,Orbital floor fracture ,eye diseases ,Surgery ,Plastic surgery ,medicine.anatomical_structure ,Otorhinolaryngology ,medicine ,medicine.symptom ,Foreign body ,business ,Orbit (anatomy) - Abstract
A 62-year-old man suffered a penetrating injury to his left periorbital region with a wooden foreign body. He consulted an ophthalmologist and plastic surgeon. He was diagnosed with a conjunctival laceration and blowout fracture. His conjunctiva was consequently sutured. One month after injury, he consulted our clinic for diplopia. Severly limited trading in the upper and lower directions were observed.Computed tomography (CT) and Magnetic resonance imaging (MRI) revealed an orbital floor fracture. When we performed an anterior orbitotomy, a 50mm long, 10mm wide wooden foreign body covered with granulation tissue in the orbit was found which had penetrated the maxillary sinus. It was removed from the orbit. In this case, wooden foreign body could not be identified preoperatively.
- Published
- 2005
- Full Text
- View/download PDF
23. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma
- Author
-
Yuki Komabayashi, Hiroya Kobayashi, Seigo Ueda, Miki Takahara, Takayuki Ohkuri, Toshihiro Nagato, Esteban Celis, Kan Kishibe, Takumi Kumai, and Yasuaki Harabuchi
- Subjects
Cancer Research ,Receptors, CCR4 ,Immunology ,C-C chemokine receptor type 7 ,C-C chemokine receptor type 6 ,Biology ,Nasal NK/T-cell lymphoma ,CCL7 ,Lymphoma, T-Cell ,Article ,Chemokine receptor ,CCL17 ,Immunology and Allergy ,Humans ,Molecular Targeted Therapy ,CCL13 ,CXCL16 ,Chemokine CCL22 ,Lymphoma, Extranodal NK-T-Cell ,CXCL2 ,Oncology ,Chemokine ,Cancer research ,CCR4 ,Chemokine CCL17 ,Immunotherapy ,Chemokines ,CCL22 ,CCL21 ,Signal Transduction - Abstract
著者最終原稿, Nasal natural killer/T-cell lymphoma (NNKTL) is associated with Epstein-Barr virus and has a poor prognosis because of local invasion and/or multiple dissemination. Various chemokines play a role in tumor proliferation and invasion, and chemokine receptors including the C-C chemokine receptor 4 (CCR4) are recognized as potential targets for treating hematologic malignancies. The aim of the present study was to determine whether specific chemokines are produced by NNKTL. We compared chemokine expression patterns in culture supernatants of NNKTL cell lines with those of other lymphoma or leukemia cell lines using chemokine protein array and ELISA. Chemokine (C-C motif) ligand (CCL) 17 and CCL22 were highly produced by NNKTL cell lines as compared to the other cell lines. In addition, CCL17 and CCL22 were readily observed in the sera of NNKTL patients. The levels of these chemokines were significantly higher in patients than in healthy controls. Furthermore, we detected the expression of CCR4 (the receptor for CCL17 and CCL22) on the surface of NNKTL cell lines and in tissues of NNKTL patients. Anti-CCR4 monoclonal antibody (mAb) efficiently induced antibody-dependent cellular cytotoxicity mediated by natural killer cells against NNKTL cell lines. Our results suggest that CCL17 and CCL22 may be important factors in the development of NNKTL and open up the possibility of immunotherapy of this lymphoma using anti-CCR4 mAb.
- Published
- 2014
24. Clinical manifestations of granulomatosis with polyangiitis (Wegener's granulomatosis) in the upper respiratory tract seen by otolaryngologists in Japan
- Author
-
Yuki Komabayashi, Yasuaki Harabuchi, and Kan Kishibe
- Subjects
Nephrology ,Adult ,Male ,medicine.medical_specialty ,Adolescent ,Physiology ,Neutrophils ,Myeloblastin ,Respiratory System ,Antibodies, Antineutrophil Cytoplasmic ,Otolaryngology ,Young Adult ,Japan ,Predictive Value of Tests ,Physiology (medical) ,Internal medicine ,Surveys and Questionnaires ,Medicine ,Humans ,cardiovascular diseases ,Young adult ,Medical diagnosis ,Aged ,Peroxidase ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Granulomatosis with Polyangiitis ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Dermatology ,Surgery ,medicine.anatomical_structure ,Otorhinolaryngology ,Predictive value of tests ,Health Care Surveys ,Female ,business ,Granulomatosis with polyangiitis ,Biomarkers ,Respiratory tract - Abstract
We studied 91 patients with granulomatosis with polyangiitis (GPA; Wegener's granulomatosis) who were dealt with by otolaryngologists in Japan. The upper respiratory tract (URT) alone was involved in 56%. Regarding findings of PR3-ANCA, histology and initial diagnosis, of the 40 patients in whom sites other than the URT were involved, 64 and 73% were positive for PR3-ANCA and histology, respectively. On the other hand, of 51 patients in whom only the URT was involved, only 49 and 31% were positive for PR3-ANCA and histology, respectively. With regard to diagnosis, definitive and probable diagnoses were made in 78 and 20%, respectively, of patients involving sites other than the URT. On the other hand, definitive and probable diagnoses were made in only 22 and 37%, respectively, of patients involving the URT alone; the Japanese diagnostic criteria were inapplicable to 41%. Of the 21 patients to whom the diagnostic criteria were inapplicable, 13 (62%) developed additional symptoms and signs during the observation period, and they then fulfilled the Japanese diagnostic criteria. Among these patients, 8 were MPO-ANCA-positive and 3 patients had 2 or more sub-lesions in the URT. If the diagnostic criteria included cases with MPO-ANCA (±) and 2 lesions in the URT, the diagnostic rates increased from 59 to 86% even though they were of limited form. Thus, about 60% of the patients with URT symptoms alone did not satisfy the Japanese diagnostic criteria at the initial visit.
- Published
- 2012
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.